These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
617 related articles for article (PubMed ID: 8685626)
1. Immunohistochemical detection of proliferative cells. Mokrý J; Nĕmecek S Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626 [TBL] [Abstract][Full Text] [Related]
2. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen. Yu CC; Dublin EA; Camplejohn RS; Levison DA Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754 [TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. Cattoretti G; Becker MH; Key G; Duchrow M; Schlüter C; Galle J; Gerdes J J Pathol; 1992 Dec; 168(4):357-63. PubMed ID: 1484317 [TBL] [Abstract][Full Text] [Related]
4. Assessment of cell proliferation in paraffin sections of normal bone marrow by the monoclonal antibodies Ki-67 and PCNA. Budke H; Orazi A; Neiman RS; Cattoretti G; John K; Barberis M Mod Pathol; 1994 Oct; 7(8):860-6. PubMed ID: 7838840 [TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma. Ghazvini S; Kroll S; Char DH; Frigillana H Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099 [TBL] [Abstract][Full Text] [Related]
6. Methodological aspects of using immunohistochemical cell proliferation biomarkers in colorectal carcinoma chemoprevention. Risio M J Cell Biochem Suppl; 1994; 19():61-7. PubMed ID: 7823607 [TBL] [Abstract][Full Text] [Related]
7. Is Ki-67 a better proliferative marker in the colon than proliferating cell nuclear antigen? Holt PR; Moss SF; Kapetanakis AM; Petrotos A; Wang S Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):131-5. PubMed ID: 9037564 [TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue. Wijsman JH; Van Dierendonck JH; Keijzer R; van de Velde CJ; Cornelisse CJ J Pathol; 1992 Sep; 168(1):75-83. PubMed ID: 1360499 [TBL] [Abstract][Full Text] [Related]
10. A cautionary note regarding the application of Ki-67 antibodies to paraffin-embedded breast cancers. Gee JM; Douglas-Jones A; Hepburn P; Sharma AK; McClelland RA; Ellis IO; Nicholson RI J Pathol; 1995 Nov; 177(3):285-93. PubMed ID: 8551391 [TBL] [Abstract][Full Text] [Related]
11. Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications. Yu CC; Filipe MI Histochem J; 1993 Dec; 25(12):843-53. PubMed ID: 7906685 [TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. Hall PA; Levison DA; Woods AL; Yu CC; Kellock DB; Watkins JA; Barnes DM; Gillett CE; Camplejohn R; Dover R J Pathol; 1990 Dec; 162(4):285-94. PubMed ID: 1981239 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of cell-cycle associated markers on paraffin embedded and formalin fixed needle biopsies of prostate cancer: correlation of p120 protein expression with AgNOR, PCNA/cyclin, Ki-67/MIB1 proliferation-scores and Gleason gradings. Botticelli AR; Casali AM; Botticelli L; Zaffe D Eur J Histochem; 1998; 42(1):41-8. PubMed ID: 9615190 [TBL] [Abstract][Full Text] [Related]
14. A comparison of proliferation markers (BrdUrd, Ki-67, PCNA) determined at each cell position in the crypts of normal human colonic mucosa. Bromley M; Rew D; Becciolini A; Balzi M; Chadwick C; Hewitt D; Li YQ; Potten CS Eur J Histochem; 1996; 40(2):89-100. PubMed ID: 8839702 [TBL] [Abstract][Full Text] [Related]
15. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings. Serio G Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759 [TBL] [Abstract][Full Text] [Related]
16. Ki-S1 and PCNA expression in erythroid precursors and megakaryocytes--a comparative study on proliferative and endoreduplicative activity in reactive and neoplastic bone marrow lesions. Thiele J; Bertsch HP; Kracht LW; Anwander T; Zimmer JD; Kreipe H; Fischer R J Pathol; 1994 May; 173(1):5-12. PubMed ID: 7523642 [TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical detection of cell proliferation-related antigens in cytologic smears of human malignant neoplasms using PC10, reactive with proliferating cell nuclear antigen, and Ki-67. A comparative study. Pelosi G; Bresaola E; Manfrin E; Rodella S; Schiavon I; Iannucci A Arch Pathol Lab Med; 1994 May; 118(5):510-6. PubMed ID: 7910728 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms. Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113 [TBL] [Abstract][Full Text] [Related]
19. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma]. Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706 [TBL] [Abstract][Full Text] [Related]
20. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors. Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]